Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

Gorar S., Culha C., Uc Z. A. , Dellal F. D. , Serter R., Aral S., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.26, no.11, pp.819-826, 2010 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 11
  • Publication Date: 2010
  • Doi Number: 10.3109/09513590.2010.487587
  • Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
  • Journal Indexes: Science Citation Index Expanded
  • Page Numbers: pp.819-826
  • Keywords: Body mass index, insulin resistance, polycystic ovary syndrome, ACTIVATED-RECEPTOR-GAMMA, METABOLIC REGULATOR, FGF-21 LEVELS, BETA-KLOTHO, OBESITY, FGF21, FIBROBLAST-GROWTH-FACTOR-21, IDENTIFICATION, EXPRESSION, GLUCOSE

Abstract

Aim. This study was designed to measure serum fibroblast growth factor 21 (FGF21) levels in patients with polycystic ovary syndrome (PCOS) and healthy subjects.